Product: MethyLPREDNISolone Acetate Injectable Suspension, USP, 400 mg/10 mL (40 mg/mL), 10 mL Multiple Dose Vial, Rx only, MFG: NorthstarRx/Teva Pharma USA, NDC 16714-090-01
Reason for recall: cGMP deviations: Temperature abuse
Recall initiated: 20220413
Status: Terminated
Classification: Class II
Recall type: Voluntary: Firm initiated